John Stamos - Public Service Announcement
Company Overview
Rational Therapeutics is successfully guiding the personalized treatment of cancer patients through a rational approach known as assay directed therapy. Since its founding in 1993, Rational Therapeutics has advanced the capabilities of assay directed therapy to find the most effective cancer treatment for a patient by analyzing an individual’s tumor response to various chemotherapies.
Rational Therapeutics is a pioneering cancer research testing center specializing in individualized therapy based on its proprietary EVA programmed cell death (EVA-PCD) assay. The assay incorporates the most advanced and accurate methodology for assessing tumor cell sensitivity to various chemotherapy drugs. Based on the fundamental belief that every cancer and every cancer patient is different, the EVA-PCD assay empowers patients to make informed and timely decisions to fight their specific cancer.
|
©2010 Rational Therapeutics. All rights reserved.